.jpg?format=webp&width=780)
A study evaluated the effectiveness of percutaneous tibial nerve stimulation (PTNS) in multiple sclerosis (MS) patients with neurogenic detrusor overactivity (NDO) who were unresponsive to pharmacological and behavioral therapies. Thirty-three patients were enrolled, and after 12 PTNS sessions, 72.4% of patients were considered responders, experiencing a reduction of at least 50% in urgency episodes. PTNS responders showed significant improvement in bladder diary results and questionnaire scores compared to those who received behavioral therapy alone. No serious adverse events were reported. This study suggests that PTNS may be an effective treatment for NDO in MS patients.
Like
Save
Share